Ergosterol

DB04038ApprovedWithdrawnSmall molecule

A steroid of interest both because its biosynthesis in FUNGI is a target of ANTIFUNGAL AGENTS, notably AZOLES, and because when it is present in SKIN of animals, ULTRAVIOLET RAYS...

Mechanism: Pharmacologically active on 7-dehydrocholesterol reductase
Curator reviewed
Formula / weight: C₂₈H₄₄O · 396.659 g/mol (avg)
First approval: Canada, 1981
Also known as: Provitamin D2

Resolves to

Compound

UNIIZ30RAY509FCAS57-87-4ChEMBLCHEMBL1232562ChEBI16933PubChem444679KEGGC01694

Structure

InChIKeyDNVPQKQSNYMLRS-APGDWVJJSA-NSMILESCC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

Targets

Q9UBM7DHCR7

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ergosterol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account